학술논문
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-To-severe atopic dermatitis: Two randomized, placebo-controlled, phase III trials
Document Type
Article
Author
Source
In: British Journal of Dermatology . (British Journal of Dermatology, February 2024, 190(2):289-291)
Subject
Language
English
ISSN
13652133
00070963
00070963